CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
ARC - Assisted Rehabilitation Caredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03787433
NCT03787433N/ACompleted
CompareCT.gov

Assisted Rehabilitation Care During Post-stroke mANaGement: fEasibiLity Assessment

Camlin Ltd·observational·Posted Dec 26, 2018·Updated Jun 16, 2020

In Brief

An observational study evaluating ARC - Assisted Rehabilitation Care for Stroke. Completed, enrolled 41 participants across 2 sites in 2 countries.

Detailed Summary

The ARCANGEL study evaluates the feasibility of introducing ARC (Assisted Rehabilitation Care), a new device for home-based post-stroke rehabilitation in the current clinical practise. All the stroke survivors included in the study will received their own equipment to be used at home for 6 months.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesItaly, United Kingdom
CollaboratorsNorthern Health and Social Care Trust, Azienda Sanitaria Locale 3, Torino

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 26, 2018
Enrollment StartNov 23, 2018
Primary CompletionJun 12, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.5 years ago

Interventions

ARC - Assisted Rehabilitation Caredevice

ARC is a platform based on wearable inertial sensors and machine learning algorithms, designed to bring the rehabilitation at post-stroke patients' home, following hospital discharge. The product has been created with the purpose to improve physical skills and patient independence accordingly, in the six months following the acute event. ARC aims to optimize, ease and make more accessible the path of post-stroke rehabilitation during post-acute phase, in real life settings.